GLI2 and FLNB Define Periocular Morphoeic Basal Cell Carcinoma
Open Access
- 25 November 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11377
Abstract
Morphoeic basal cell carcinoma (mBCC) has a higher risk of local recurrence than the more indolent nodular (nodBCC) subtype. Little is known about the genetic and molecular makeup of mBCC that determines its invasive behaviour: a comparison of mBCC with nodBCC was carried out. Whole-exome sequencing (WES) of 20 BCC tumours (10 eyelid morphoeic and 10 nodular) underwent driver gene detection using OncodriveFM and MutSigCV, followed by a randomisation analysis procedure. Samples underwent RNA sequencing, gene-set enrichment analysis and candidates verified by RT-PCR. PTCH1, FLNB, and double-knockdown human keratinocyte models were used to validate phenotype and gene expression. Hedgehog pathway analysis of 20 additional BCCs underwent immunostaining verification. Our analysis revealed FLNB as a potential driver with a mutational cluster in FLNB Filamin domain 24 and a 4-fold reduction in expression compared to normal eyelids in mBCC only. FLNB knockdown demonstrated an mBCC phenotype. Aberrant Gli2 dominant hedgehog (Hh) signalling was seen in mBCC on three molecular levels: mutational significance, transcriptome profile, and protein expression. Gli2-dominant Hh overexpression was seen in the tumour plus stroma of eyelid morphoeic but not nodular BCC. FLNB is a potential tumour suppressor, with its loss producing a morphoeic phenotype in vitro.Keywords
Funding Information
- Fight for Sight Fellowship (1327/28)
- NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
- Cancer Research UK Centre of Excellence Award to Barts Cancer Centre (C16420/A18066)
This publication has 75 references indexed in Scilit:
- Chronic inflammation and cancer; the two sides of a coinLife Sciences, 2023
- Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelinesEuropean Journal of Cancer, 2019
- Basal cell carcinomaJournal of the American Academy of Dermatology, 2019
- The Tumor-Promoting Role of TRIP4 in Melanoma Progression and its Involvement in Response to BRAF-Targeted TherapyJournal of Investigative Dermatology, 2018
- GLI2 Is a Regulator of β-Catenin and Is Associated with Loss of E-Cadherin, Cell Invasiveness, and Long-Term Epidermal RegenerationJournal of Investigative Dermatology, 2017
- Hedgehog signaling in basal cell carcinomaJournal of Dermatological Science, 2015
- Genetic variation in C12orf51 is associated with prognosis of intestinal-type gastric cancer in a Chinese populationBiomedicine & Pharmacotherapy, 2015
- Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinomaMolecular Oncology, 2014
- Location of gene for Gorlin syndromeThe Lancet, 1992
- Familial basal cell nevus syndromeHuman Genetics, 1978